VAREX IMAGING Cash on Hand 2015-2019 | VREX

VAREX IMAGING cash on hand from 2015 to 2019. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
VAREX IMAGING Annual Cash on Hand
(Millions of US $)
2018 $52
2017 $83
2016 $37
2015 $21
2014 $
VAREX IMAGING Quarterly Cash on Hand
(Millions of US $)
Q3 2019 $29
Q2 2019 $31
Q1 2018 $55
Q4 2018 $52
Q3 2018 $53
Q2 2018 $55
Q1 2017 $94
Q4 2017 $83
Q3 2017 $89
Q2 2017 $80
Q1 2016 $54
Q4 2016 $37
Q3 2016
Q2 2016
Q1 2015
Q4 2015 $21
Q4 2014
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.120B $0.773B
Varex Imaging Corporation is an innovator, designer and manufacturer of X-ray imaging components which include tubes, digital flat panel detectors and other image processing solutions. Its components are used in medical imaging as well as industrial and security imaging applications. The company operates primarily in North America, Europe and Asia. Varex Imaging Corporation is based in Salt Lake City, United States.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $142.346B 25.98
Medtronic (MDT) Ireland $140.191B 19.68
Stryker (SYK) United States $78.472B 27.14
Boston Scientific (BSX) United States $53.184B 25.80
Baxter (BAX) United States $44.439B 26.95
EssilorLuxottica Societe Anonyme (ESLOY) France $32.258B 0.00
Zimmer Biomet Holdings (ZBH) United States $27.681B 17.72
Lonza Group Ag (LZAGY) Switzerland $25.900B 0.00
Coloplast (CLPBY) Denmark $25.812B 41.21
Terumo (TRUMY) Japan $24.350B 30.39
Smith & Nephew SNATS (SNN) United Kingdom $19.056B 0.00
ResMed (RMD) United States $18.190B 34.66
Sunny Optical Technology (SNPTF) China $16.387B 0.00
Bio-Rad Laboratories (BIO) United States $10.237B 54.88
Insulet (PODD) United States $9.093B 538.82
Perrigo (PRGO) Ireland $7.366B 13.57
Canopy Growth (CGC) Canada $7.357B 0.00
Hill-Rom Holdings (HRC) United States $6.647B 19.82
DiaSorin S.p.A (DSRLF) Italy $6.420B 0.00
Haemonetics (HAE) United States $6.263B 47.27
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.231B 27.02
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.841B 0.00
Aurora Cannabis (ACB) Canada $3.683B 0.00
NuVasive (NUVA) United States $3.480B 27.74
Neogen (NEOG) United States $3.394B 56.79
ICU Medical (ICUI) United States $3.208B 20.81
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.707B 0.00
Quidel (QDEL) United States $2.500B 24.83
Agios Pharmaceuticals (AGIO) United States $1.911B 0.00
National Vision Holdings (EYE) United States $1.831B 39.53
Cardiovascular Systems (CSII) United States $1.652B 0.00
Aphria (APHA) $1.225B 0.00
AtriCure (ATRC) United States $1.018B 0.00
Phibro Animal Health (PAHC) United States $0.901B 14.66
Eagle Pharmaceuticals (EGRX) United States $0.852B 21.72
Omeros (OMER) United States $0.765B 0.00
NanoString Technologies (NSTG) United States $0.764B 0.00
PetIQ (PETQ) United States $0.745B 17.59
Lantheus Holdings (LNTH) United States $0.717B 18.85
LeMaitre Vascular (LMAT) United States $0.693B 41.07
Cerus (CERS) United States $0.619B 0.00
Surmodics (SRDX) United States $0.595B 113.13
MacroGenics (MGNX) United States $0.539B 0.00
TG Therapeutics (TGTX) United States $0.527B 0.00
OraSure Technologies (OSUR) United States $0.512B 23.69
Quanterix (QTRX) United States $0.507B 0.00
Owens & Minor (OMI) United States $0.456B 13.66
Meridian Bioscience (VIVO) United States $0.427B 13.33
Utah Medical Products (UTMD) United States $0.348B 25.47
BioLife Solutions (BLFS) United States $0.337B 103.38
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.311B 0.00
Zynex (ZYXI) United States $0.305B 32.45
Bovie Medical (APYX) United States $0.224B 0.00
United Health Products (UEEC) United States $0.221B 0.00
Vapotherm (VAPO) United States $0.179B 0.00
Repro-Med Systems (REPR) United States $0.155B 0.00
Cytosorbents (CTSO) United States $0.155B 0.00
Rockwell Medical (RMTI) United States $0.154B 0.00
Fonar (FONR) United States $0.129B 9.06
Female Health (VERU) United States $0.128B 0.00
InfuSystems Holdings (INFU) United States $0.127B 0.00
Liberty Health Sciences (LHSIF) Canada $0.110B 0.00
Chembio Diagnostics (CEMI) United States $0.100B 0.00
United-Guardian (UG) United States $0.085B 20.00
Chimerix (CMRX) United States $0.082B 0.00
Nephros (NEPH) United States $0.077B 0.00
MTech Acquisition (KERN) United States $0.061B 0.00
MRI Interventions (MRIC) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.054B 0.00
Surface Oncology (SURF) United States $0.038B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Senestech (SNES) United States $0.022B 0.00
GUARDION HEALTH (GHSI) United States $0.018B 0.00
Trinity Biotech (TRIB) Ireland $0.018B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Myomo (MYO) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00